We are live on ! Find out more
BP

BCK Partners Portfolio holdings

AUM $207M
1-Year Est. Return 18%
This Fund
S&P 500
This Quarter Est. Return
+5.1%
1 Year Est. Return
+18%
3 Year Est. Return
+44.58%
5 Year Est. Return
+37.67%
10 Year Est. Return
–
AUM
$151M
AUM Growth
+$11M
Cap. Flow
+$8.21M
Cap. Flow %
5.43%
Top 10 Hldgs %
95.65%
Holding
28
New
1
Increased
8
Reduced
7
Closed
–

Top Buys

Rank Stock Value
1
VCSH icon
Vanguard Short-Term Corporate Bond ETF
VCSH
+$6.28M
2
IGIB icon
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
+$2.81M
3
TMO icon
Thermo Fisher Scientific
TMO
+$193K
4
SCHF icon
Schwab International Equity ETF
SCHF
+$74.3K
5
SCHE icon
Schwab Emerging Markets Equity ETF
SCHE
+$63.7K

Top Sells

Rank Stock Value
1
VOO icon
Vanguard S&P 500 ETF
VOO
+$477K
2
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$407K
3
VB icon
Vanguard Morningstar Small-Cap ETF
VB
+$169K
4
SCHA icon
Schwab U.S Small- Cap ETF
SCHA
+$125K
5
MSFT icon
Microsoft
MSFT
+$10.9K

Sector Composition

Rank Sector Weight
1 Technology 1.74%
2 Healthcare 1.14%
3 Financials 0.53%
4 Industrials 0.28%
5 Consumer Discretionary 0.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TMO icon
26
Thermo Fisher Scientific
TMO
$213B
$207K 0.14%
+410
New +$193K
1
2

Similar funds

MPCG
Matrix Private Capital Group New York $207M AUM 16.87% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
SNBOSD
Security National Bank of So Dak Sioux City, Iowa $207M AUM 21.03% 1-Year Est. Return
BWM
Birchcreek Wealth Management Miami Township, Ohio $208M AUM 18.75% 1-Year Est. Return
CC
CIBRA Capital London, United Kingdom $207M AUM
HCA
Hyperion Capital Advisors New York $208M AUM 10.31% 1-Year Est. Return
KIC
Kensington Investment Counsel Long Beach, California $208M AUM 11.99% 1-Year Est. Return
JWM
Johnson Wealth Management Grand Forks, North Dakota $207M AUM

BCK Partners's Q2 2021 Portfolio in Review

As of Q2 2021, BCK Partners held 28 positions worth $151M, up 7.9% from $140M the previous quarter. Its ten largest holdings account for 96% of the portfolio.

BCK Partners deployed $8.21M of net new capital in Q2 2021, opening 1 new position and adding to 8 existing holdings. Its largest new stake was Thermo Fisher Scientific: 410 shares worth $207K.

By sector, the portfolio is most concentrated in Technology at 1.7% of assets, down from 2% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $477K trimmed.

  • BCK Partners's largest Q2 2021 buy was Thermo Fisher Scientific: 410 shares worth $207K.
  • BCK Partners added most to Vanguard Short-Term Corporate Bond ETF in Q2 2021, an estimated $6.28M increase.
  • BCK Partners's biggest Q2 2021 reduction was Vanguard S&P 500 ETF, cutting an estimated $477K.
  • BCK Partners's ten largest holdings make up 96% of its $151M portfolio in Q2 2021.
  • BCK Partners opened 1 new position and closed 0 in Q2 2021.
  • BCK Partners's portfolio value rose 7.9% quarter-over-quarter to $151M.

Based on BCK Partners's 13F filing for Q2 2021, filed 10 Aug 2021.